s
Targeted Pre-Launch Scientific Outreach Drives 40% Faster Treatment Adoption
25-07-2024, 15:06
New Veeva Pulse findings show congresses and early-career experts have the strongest influence on patient outcomes BARCELONA, Spain, July 25, 2024 /PRNewswire/ — Veeva Systems (NYSE: VEEV) today revealed that targeted pre-launch scientific outreach maximizes medical affairs teams’ impact on treatment adoption in the latest Veeva Pulse Field Trends Report. The analysis shows biopharmas investing […] L'articolo Targeted Pre-Launch Scientific Outreach Drives 40% Faster Treatment Adoption proviene da La Ragione.
CONTINUA A LEGGERE
13
0
0
Guarda anche
Libero Quotidiano
